McLoughlin Margaret 4
4 · Cortexyme, Inc. · Filed Aug 18, 2021
Insider Transaction Report
Form 4
Cortexyme, Inc.CRTX
McLoughlin Margaret
Director
Transactions
- Sale
Common Stock
2021-08-16$97.55/sh−423$41,264→ 48 total - Sale
Common Stock
2021-08-16$98.90/sh−48$4,747→ 0 total - Sale
Common Stock
2021-08-16$95.57/sh−1,044$99,775→ 1,900 total - Exercise/Conversion
Stock Option (right to buy)
2021-08-16−6,000→ 85,911 totalExercise: $17.00Exp: 2029-05-07→ Common Stock (6,000 underlying) - Exercise/Conversion
Common Stock
2021-08-16$17.00/sh+6,000$102,000→ 6,000 total - Sale
Common Stock
2021-08-16$94.55/sh−3,056$288,945→ 2,944 total - Sale
Common Stock
2021-08-16$96.51/sh−1,429$137,913→ 471 total
Footnotes (6)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 24, 2020.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.06 to $95.06, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $95.07 to $96.07, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.12 to $97.04, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F5]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $97.22 to $97.97, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F6]The option vested as to 1/3rd of the shares on May 8, 2020, with the remaining 2/3rd of shares vesting in equal monthly installments beginning on June 8, 2020 and ending on May 8, 2022.